Zynerba Pharmeceuticals, Inc.
Formerly AllTranz, Inc.
Zynerba Pharmeceuticals, Inc. is listed today as Zynerba Pharmaceuticals: market value, financials and filings are on its company page.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
Funding rounds of Zynerba Pharmeceuticals, Inc.| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|
| Sep 2014 | $7 M | No. 1 | $2 to $10 million | | equity, options | SEC |
What its filings and its own website say, sentence by sentence, each with its source.
Zynerba Pharmeceuticals, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2014).
SEC Form D · Oct 2014
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Oct 2014
No products or services of Zynerba Pharmeceuticals, Inc. are on record.
1 named in official filings. Open an investor to see everything it has backed.
Investors in Zynerba Pharmeceuticals, Inc.| Investor | Kind | Amount | Round | Role | Source |
|---|
| Michael Rapp | Person | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by Zynerba Pharmeceuticals, Inc.| Name | Role | Named in |
|---|
| Armando Anindo | Executive officer | Oct 2014 |
| Suzanne B. Hanlon | Executive officer | Oct 2014 |
| Terri B. Sebree | Executive officer | Oct 2014 |
| Armando Anindo | Director | Oct 2014 |
| Philip Wagenheim | Director | Oct 2014 |
| Steven Gailar | Director | Oct 2014 |
Company in Radnor, United States.